OBJECTIVE: Pulmonary surfactant protein B (SP-B), an alveolar protein normally detectable at only very low concentrations in blood, circulates at higher levels among smokers and those with alveolar injury and inflammation. We hypothesized that SP-B may serve as a marker of the vascular effects of smoking and would thus be associated with subclinical measures of atherosclerosis. METHODS AND RESULTS: Plasma levels of SP-B were measured in 3294 subjects, ages 30 to 65, enrolled in the Dallas Heart Study, a probability-based population sample of Dallas County adults. Coronary artery calcium (CAC) was measured by computed tomography and abdominal aortic plaque (AP) by magnetic resonance imaging. The cohort comprised 29% current and 17% former smokers. The overall prevalence of CAC was 22%, and that of AP was 39%. Median SP-B levels were 5-fold higher among current versus never smokers (P<0.0001) and were significantly correlated with estimated pack-years smoked (Spearman ρ=0.35, P<0.0001). Increasing levels of SP-B also associated with other traditional cardiac risk factors and higher levels of inflammatory biomarkers. In univariable analyses, increasing SP-B quartiles associated with higher prevalence of both CAC and AP (P(trend)<0.0001 for each). In multivariable analyses adjusting for traditional cardiovascular risk factors, SP-B remained associated with AP (OR 1.87 for the 4th versus 1st quartiles, 95% confidence interval 1.39 to 2.51; P<0.0001) but not CAC. An interaction was observed between SP-B, smoking status, and AP (P(interaction)=0.01), such that SP-B associated with AP in current smokers (adjusted OR 2.15 for the 4th versus 1st quartile, 95% confidence interval 1.26 to 3.67; P=0.005) but not in former or never smokers. CONCLUSIONS: Circulating levels of SP-B increase with greater smoking burden and independently associate with abdominal AP among current smokers. Our findings support further investigation of the role of SP-B as a marker of the vascular effects of smoking.
OBJECTIVE: Pulmonary surfactant protein B (SP-B), an alveolar protein normally detectable at only very low concentrations in blood, circulates at higher levels among smokers and those with alveolar injury and inflammation. We hypothesized that SP-B may serve as a marker of the vascular effects of smoking and would thus be associated with subclinical measures of atherosclerosis. METHODS AND RESULTS: Plasma levels of SP-B were measured in 3294 subjects, ages 30 to 65, enrolled in the Dallas Heart Study, a probability-based population sample of Dallas County adults. Coronary artery calcium (CAC) was measured by computed tomography and abdominal aortic plaque (AP) by magnetic resonance imaging. The cohort comprised 29% current and 17% former smokers. The overall prevalence of CAC was 22%, and that of AP was 39%. Median SP-B levels were 5-fold higher among current versus never smokers (P<0.0001) and were significantly correlated with estimated pack-years smoked (Spearman ρ=0.35, P<0.0001). Increasing levels of SP-B also associated with other traditional cardiac risk factors and higher levels of inflammatory biomarkers. In univariable analyses, increasing SP-B quartiles associated with higher prevalence of both CAC and AP (P(trend)<0.0001 for each). In multivariable analyses adjusting for traditional cardiovascular risk factors, SP-B remained associated with AP (OR 1.87 for the 4th versus 1st quartiles, 95% confidence interval 1.39 to 2.51; P<0.0001) but not CAC. An interaction was observed between SP-B, smoking status, and AP (P(interaction)=0.01), such that SP-B associated with AP in current smokers (adjusted OR 2.15 for the 4th versus 1st quartile, 95% confidence interval 1.26 to 3.67; P=0.005) but not in former or never smokers. CONCLUSIONS: Circulating levels of SP-B increase with greater smoking burden and independently associate with abdominal AP among current smokers. Our findings support further investigation of the role of SP-B as a marker of the vascular effects of smoking.
Authors: Farouc A Jaffer; Christopher J O'Donnell; Martin G Larson; Stephen K Chan; Kraig V Kissinger; Michelle J Kupka; Carol Salton; Rene M Botnar; Daniel Levy; Warren J Manning Journal: Arterioscler Thromb Vasc Biol Date: 2002-05-01 Impact factor: 8.311
Authors: Tulika Jain; Ronald Peshock; Darren K McGuire; DuWayne Willett; Zhoaxia Yu; Zhoazia Yu; Gloria L Vega; Rudy Guerra; Helen H Hobbs; Scott M Grundy Journal: J Am Coll Cardiol Date: 2004-09-01 Impact factor: 24.094
Authors: Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs Journal: Am J Cardiol Date: 2004-06-15 Impact factor: 2.778
Authors: Marie-Luise Brennan; Marc S Penn; Frederick Van Lente; Vijay Nambi; Mehdi H Shishehbor; Ronnier J Aviles; Marlene Goormastic; Michael L Pepoy; Ellen S McErlean; Eric J Topol; Steven E Nissen; Stanley L Hazen Journal: N Engl J Med Date: 2003-10-23 Impact factor: 91.245
Authors: Peter H Whincup; Julie A Gilg; Jonathan R Emberson; Martin J Jarvis; Colin Feyerabend; Andrew Bryant; Mary Walker; Derek G Cook Journal: BMJ Date: 2004-06-30
Authors: Carmine G De Pasquale; Leonard F Arnolda; Ian R Doyle; Philip E Aylward; Derek P Chew; Andrew D Bersten Journal: Circulation Date: 2004-08-09 Impact factor: 29.690
Authors: Chantal Kopecky; Michael Haidinger; Ruth Birner-Grünberger; Barbara Darnhofer; Christopher C Kaltenecker; Gunther Marsche; Michael Holzer; Thomas Weichhart; Marlies Antlanger; Johannes J Kovarik; Johannes Werzowa; Manfred Hecking; Marcus D Säemann Journal: J Am Soc Nephrol Date: 2014-07-28 Impact factor: 10.121
Authors: Lu Q Chen; Anand Rohatgi; Colby R Ayers; Sandeep R Das; Amit Khera; Jarett D Berry; Darren K McGuire; James A de Lemos Journal: Atherosclerosis Date: 2011-08-22 Impact factor: 5.162
Authors: Kathleen V Fitch; Sara E Looby; Alison Rope; Peace Eneh; Linda Hemphill; Hang Lee; Steven K Grinspoon Journal: AIDS Date: 2013-01-02 Impact factor: 4.177
Authors: Chantal Kopecky; Bernd Genser; Christiane Drechsler; Vera Krane; Christopher C Kaltenecker; Markus Hengstschläger; Winfried März; Christoph Wanner; Marcus D Säemann; Thomas Weichhart Journal: Clin J Am Soc Nephrol Date: 2014-11-25 Impact factor: 8.237
Authors: Ayumu Taguchi; Samir Hanash; Andrew Rundle; Ian W McKeague; Deliang Tang; Salima Darakjy; J Michael Gaziano; Howard D Sesso; Frederica Perera Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07-29 Impact factor: 4.254